These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 6277474

  • 1. Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
    Inaba M, Fukui M, Yoshida N, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1982 Mar; 42(3):1103-6. PubMed ID: 6277474
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.
    Johnston HP, Hawley P, White SE, Gibson I, Tidd DM.
    Br J Cancer; 1985 Apr; 51(4):505-14. PubMed ID: 3838480
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T, Akahori Y, Sakurai Y.
    Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
    [Abstract] [Full Text] [Related]

  • 9. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M.
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells.
    Plagemann PG, Wohlhueter RM.
    Cancer Res; 1985 Dec; 45(12 Pt 1):6418-24. PubMed ID: 3877568
    [Abstract] [Full Text] [Related]

  • 13. [Cross-resistance of HO-221 and various antitumor agents in sublines of mouse leukemia].
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Fujimoto S, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):201-9. PubMed ID: 1899547
    [Abstract] [Full Text] [Related]

  • 14. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
    Sladek NE, Landkamer GJ.
    Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06.
    Zeng H, Lin ZP, Sartorelli AC.
    Biochem Pharmacol; 2004 Sep 01; 68(5):911-21. PubMed ID: 15294454
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Collateral sensitivity to cross-linking agents exhibited by cultured L1210 cells resistant to oxazaphosphorines.
    Sladek NE, Low JE, Landkamer GJ.
    Cancer Res; 1985 Feb 01; 45(2):625-9. PubMed ID: 3967238
    [Abstract] [Full Text] [Related]

  • 19. Biochemical characteristics of a 5-fluorouracil-resistant subline of P388 leukemia.
    Tezuka M, Sugiyama H, Tamemasa O, Inaba M.
    Gan; 1982 Feb 01; 73(1):70-6. PubMed ID: 7117749
    [Abstract] [Full Text] [Related]

  • 20. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Visalli M, Bisagni E, Pierré A, Atassi G.
    Cancer Chemother Pharmacol; 1996 Feb 01; 38(6):513-21. PubMed ID: 8823492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.